October 25, 2015 'Stunning' number of extreme drug doses by doc, expert says A Harvard medical professor says patients of a Detroit-area cancer doctor were at high risk of infection because of excessive doses of powerful, expensive drugs.
October 25, 2015 The hidden dangers of taking common painkillers It’s easy to reach for your go-to painkiller when you need it. The medication may seem like a harmless fix, but a growing body of research suggests that may not be the case.
October 25, 2015 Texas health officials issue measles alert Texas health officials have issued a measles alert and are urging people to be immunized after more than a dozen cases were reported this year.
October 25, 2015 Call for overhaul of drug industry business model Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.
October 25, 2015 Antidepressants have sexual side effects in teens, too When teens take pills for depression and anxiety, doctors need to make sure they understand that sexual side effects are common with the drugs, a new paper advises.
October 25, 2015 Cancer studies often downplay chemo side effects Doctors relying on studies published in top journals for guidance about how to treat women with breast cancer may not be getting the most accurate information, according to a new analysis
October 25, 2015 Dispute flares within FDA over safety of popular blood pressure drugs The top-selling class of blood-pressure drugs is under attack from an unusual source: a senior regulator at the Food and Drug Administration.
October 25, 2015 Quit-smoking drug Chantix may be safe for patients with treated depression, study shows In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S. as Chantix - were no more prone to depression or thoughts of suicide than those on a placebo, according to a new study.
October 25, 2015 FDA approves new use for Celgene's cancer drug Revlimid The U.S. Food and Drug Administration has expanded the authorized use of Celgene Corp's cancer drug Revlimid to include newly diagnosed patients with multiple myeloma, the company said on Wednesday.
October 25, 2015 Popping Xanax is more harmful than you think Xanax may be trendy, but it can affect your health.
